Erik Wallström
Sanofi (United States)(US)
Publications by Year
Research Areas
Multiple Sclerosis Research Studies, T-cell and B-cell Immunology, Immunotherapy and Immune Responses, Cytokine Signaling Pathways and Interactions, interferon and immune responses
Most-Cited Works
- → Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study(2018)906 cited
- → Autoimmunity to Myelin Oligodendrocyte Glycoprotein in Rats Mimics the Spectrum of Multiple Sclerosis Pathology(1998)522 cited
- → Variation in interleukin 7 receptor α chain (IL7R) influences risk of multiple sclerosis(2007)479 cited
- → The selective sphingosine 1‐phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species‐specific effects on heart rate(2012)302 cited
- → MHC haplotype-dependent regulation of MOG-induced EAE in rats.(1998)255 cited
- → Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study(2013)232 cited
- → T Cell Ig- and Mucin-Domain-Containing Molecule-3 (TIM-3) and TIM-1 Molecules Are Differentially Expressed on Human Th1 and Th2 Cells and in Cerebrospinal Fluid-Derived Mononuclear Cells in Multiple Sclerosis(2004)213 cited
- → Pivotal Advance: HMGB1 expression in active lesions of human and experimental multiple sclerosis(2008)211 cited
- → Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial(2021)179 cited
- → CX3CL1 (fractalkine) and CX3CR1 expression in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis: kinetics and cellular origin(2005)123 cited